rs1060503102
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001040142.2(SCN2A):c.4876C>T(p.Arg1626*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001040142.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN2A | ENST00000375437.7 | c.4876C>T | p.Arg1626* | stop_gained | Exon 27 of 27 | 5 | NM_001040142.2 | ENSP00000364586.2 | ||
SCN2A | ENST00000631182.3 | c.4876C>T | p.Arg1626* | stop_gained | Exon 27 of 27 | 5 | NM_001371246.1 | ENSP00000486885.1 | ||
SCN2A | ENST00000283256.10 | c.4876C>T | p.Arg1626* | stop_gained | Exon 27 of 27 | 1 | ENSP00000283256.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.4876C>T (p.R1626*) alteration, located in exon 27 (coding exon 26) of the SCN2A gene, consists of a C to T substitution at nucleotide position 4876. This changes the amino acid from an arginine (R) to a stop codon at amino acid position 1626. This alteration occurs at the 3' terminus of the SCN2A gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 19% of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). Based on data from the Genome Aggregation Database (gnomAD), the SCN2A c.4876C>T alteration was not observed, with coverage at this position. This variant was reported to occur de novo in an autism cohort (Stessman, 2017). Based on the available evidence, this alteration is classified as likely pathogenic. -
Seizures, benign familial infantile, 3;C3150987:Developmental and epileptic encephalopathy, 11 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Family studies have indicated that this variant was not present in the parents of an individual with clinical features of epilepsy, which suggests that it was de novo in that affected individual (Invitae). A missense change at the same codon (p.Arg1626Gln) has been reported as a de novo variant in 2 individuals affected with seizures (PMID: 25937001, 25473036). This suggests that this amino acid residue is essential for proper function of the SCN2A protein. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a SCN2A-related disease. This sequence change results in a premature translational stop signal in the last exon of the SCN2A mRNA at codon 1626 (p.Arg1626*). While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated SCN2A protein. -
not provided Pathogenic:1
Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 380 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28191889, 33004838) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at